Chemists develop a new way to treat antibiotic-resistant infections

November 5, 2018, Stanford University
Credit: CC0 Public Domain

With drug-resistant infections on the rise and the development of new antibiotics on the decline, the world could use a new strategy in the fight against increasingly wily bacteria. Now, Stanford chemists report November 2 in the Journal of the American Chemical Society a possible solution: a small molecular attachment that helps conventional antibiotics penetrate and destroy their targets.

The attachment, known as r8, helps guide through a bacterium's outer defenses and encourages them to linger, said Alexandra Antonoplis, a graduate student in chemistry and co-lead author with fellow chemistry graduate student Xiaoyu Zang. That penetration and tenacity help kill bacteria, such as methicillin-resistant Staphylococcus aureus, or MRSA, that doctors would otherwise struggle to stop.

Indeed, adding r8 to vancomycin, a first-line defense against MRSA, made the new drug hundreds of times more effective, according to experiments conducted by Antonoplis, Zang, and their advisers, Lynette Cegelski, an associate professor of chemistry, and Paul Wender, the Francis W. Bergstrom Professor of Chemistry. The same strategy, the researchers believe, could apply beyond MRSA to other drugs and infections.

"You don't have to invent a new drug. You just have to fix the problems with existing drugs," said Wender, who is also a member of Stanford Bio-X, the Stanford Cancer Institute, and Stanford ChEM-H.

The MRSA problem

In the long run, the new approach could be good news for public health officials who have struggled with how to deal with antibiotic-resistant infections like MRSA. That infection, which often begins as a skin infection, causes more than half of hospital-related infections in Asia and the Americas, and it is the leading cause of death among antibiotic-resistant infections.

"It's a global health problem, and we need new treatment strategies, because of the increasing emergence of bacteria that are resistant to antibiotics and the limited number of antibiotics in our pipeline," said Cegelski who is also a member of Stanford Bio-X and Stanford ChEM-H. According to one report, the number of new FDA-approved antibiotics dropped 90 percent over the last three decades. The current first-line treatment for MRSA has been in use since 1958.

That first-line treatment, the antibiotic vancomycin, can keep MRSA from spreading in some cases by preventing the construction of new bacterial cell walls, thus preventing the bacteria from reproducing.

But vancomycin is largely useless against two of the bacteria's key defenses. First, MRSA has a tendency to form biofilms, colonies of the bacteria embedded within a protective membrane that drugs have a hard time penetrating. Second, MRSA bacteria can lie dormant for extended periods, during which time vancomycin doesn't work—meaning doctors need an antibiotic that can stick around until MRSA bacteria start to wake up.

Antibiotic siege tactics

The solution, the Stanford team believed, lies not in designing an antibiotic from the ground up, but rather in modifying vancomycin with r8 to help it break into a biofilm and stick around long enough to attack cells once they awaken.

To test vancomycin with the attached r8, dubbed V-r8, the team pitted both it and vancomycin against MRSA in a free-floating state and in biofilms. When bacteria were floating around freely in a liquid, both vancomycin and V-r8 were able to kill off most of the bacteria. But in biofilms, V-r8 was around 10 times more effective, demonstrating that it could penetrate a biofilm and kill bacteria inside. V-r8 also clung to MRSA bacteria twice as well as vancomycin and was vastly more effective at entering MRSA cells, suggesting it could hang around long enough to kill dormant cells.

Those experiments, however, were all conducted in lab dishes. To see how V-r8 would do in a real , the team treated mice infected with MRSA with both V-r8 and vancomycin. The new version, they found, killed about 97 percent of bacteria after five hours, about six times more effective than without the r8 attachment.

The results do not mean that a new antibiotic is headed straight to the clinic, even for testing—that is likely still years away. Still, Wender said, they do suggest a new way to build antibiotics: by modifying existing antibiotics with synthetic components to give them new abilities, such as the capacity to break through biofilms.

The team next intends to test the drug-modifying strategy in other in the hope of finding similar results and a way forward in dealing with antibiotic resistance.

"This was just the first effort," Cegelski said.

Explore further: Supercharged antibiotics could turn tide against superbugs

More information: Alexandra Antonoplis et al, A dual function antibiotic-transporter conjugate exhibits superior activity in sterilizing MRSA biofilms and killing persister cells, Journal of the American Chemical Society (2018). DOI: 10.1021/jacs.8b08711

Related Stories

Tick protein helps antibiotics combat MRSA super bug

April 27, 2017

A protein derived from ticks enhances the effectiveness of antibiotic treatment for methicillin-resistant Staphylococcus aureus, or MRSA, according to a Yale-led study. The strategy of using the protein in combination with ...

Fighting MRSA with new membrane-busting compounds

March 15, 2017

Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA). The bacteria have developed resistance to a number of treatments, even antibiotics of last resort in some cases. ...

Recommended for you

The powerful meteor that no one saw (except satellites)

March 19, 2019

At precisely 11:48 am on December 18, 2018, a large space rock heading straight for Earth at a speed of 19 miles per second exploded into a vast ball of fire as it entered the atmosphere, 15.9 miles above the Bering Sea.

Revealing the rules behind virus scaffold construction

March 19, 2019

A team of researchers including Northwestern Engineering faculty has expanded the understanding of how virus shells self-assemble, an important step toward developing techniques that use viruses as vehicles to deliver targeted ...

OSIRIS-REx reveals asteroid Bennu has big surprises

March 19, 2019

A NASA spacecraft that will return a sample of a near-Earth asteroid named Bennu to Earth in 2023 made the first-ever close-up observations of particle plumes erupting from an asteroid's surface. Bennu also revealed itself ...

Nanoscale Lamb wave-driven motors in nonliquid environments

March 19, 2019

Light driven movement is challenging in nonliquid environments as micro-sized objects can experience strong dry adhesion to contact surfaces and resist movement. In a recent study, Jinsheng Lu and co-workers at the College ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.